Celldex Therapeutics reported $-80.62M in EBIT for its fiscal quarter ending in June of 2026.





Ebit Change Date
AbbVie USD 6.72B 1.99B Jun/2026
Agenus USD 15.05M 656K Mar/2026
Amgen USD 4.61B 777M Jun/2026
Bristol-Myers Squibb USD 299M 3.26B Jun/2026
Celldex Therapeutics USD -80.62M 3.81M Jun/2026
Glaxosmithkline GBP 2.31B 14.92M Mar/2026
Nektar Therapeutics USD -38.26M 19.17M Mar/2026
Northwest Biotherapeutics USD -10.9M 3.42M Mar/2026
Pfizer USD -180M 5.16B Jun/2026
Rigel Pharmaceuticals USD 447K 1.52M Jun/2024
Roche Holding CHF 11.46B 1.91B Jun/2026